The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Apple, Apptio, Cheniere Energy, First Solar, Kratos Defense & Security Solutions, Smartsheet,...
Two research firms have called for major upside ahead Aldeyra Therapeutics, even after the big pop in the stock on Wednesday.
The top analyst upgrades, downgrades and initiations seen on Thursday included Advanced Micro Devices, Amazon, Apple, Bed Bath & Beyond, Citigroup, Mastercard, Paypal, Square and Visa.
The top analyst upgrades, downgrades and initiations seen on Thursday include American Superconductor, Galapagos, Humana, Intel, Philips Electronics, Pinduoduo, Qualcomm and Wayfair.
Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial.
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well. One key analyst has decided to weigh in on the firm and where it stands to go from here.
Corey Davis and Lidia Liu of Canaccord Genuity started Aldeyra Therapeutics with a Buy rating and they issued a $16.00 price target.
Wednesday's top analyst upgrades, downgrades and initiations include Brinker International, Cypress Semiconductor, Starbucks and Windstream.
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero Energy and Virtu Financial.
With Dow Jones Industrial Average and S&P 500 Index hitting new highs, investors are now looking for new ideas and value stocks that they might have overlooked.
Source: ThinkstockWe previewed three initial public offerings (IPO) scheduled to begin trading last week, but we got fooled. Two, which had already been postponed at least once, were joined by the...
Source: ThinkstockOf the dozen initial public offerings (IPOs) scheduled for last week, all but one made it out the door. That one is now scheduled for the coming week along with one more that has...
Source: ThinkstockThe second quarter of 2014 is off to a fast start on the initial public offering (IPO) front. Eight companies completed IPOs last week, and another dozen are scheduled to price and...